The setback likely removes one competitor to an emerging spinal muscular atrophy medicine from Scholar Rock, but sets the ...

Vertex Pharmaceuticals offers a buying opportunity with strong Q3 earnings, robust pipeline, and healthy financials ...

We recently made a list of Goldman Sachs’ Top Growth Investors: 34 Stocks With The Highest Investment For Growth. In this ...